ForteBio Lands $25M in Series C Financing

Sep 25, 2008

NEW YORK (GenomeWeb News) – ForteBio has reeled in $25 million in venture capital financing from existing and new investors, the Menlo Park, Calif.-based company said this week.

The Series C financing was led by new investor OrbiMed Advisors, and included investments from another new investor MPM Capital, and existing investors Alloy Ventures, Latterell Venture Partners, the Vertical Group, and Versant Ventures.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Breaking News

The Scan

Getting It Early

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

Food Bugs to Meet Sequencers

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

From Ancient Bathrooms

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

This Week in Nature

In Nature this week: ash dieback disease fungal genome, and more.

Main menu